Prelude Therapeutics
PRLD
#9727
Rank
โ‚ฌ31.5 M
Marketcap
0,57ย โ‚ฌ
Share price
-3.63%
Change (1 day)
-86.84%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -2,01ย โ‚ฌ

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -1,98ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,23ย โ‚ฌ a decrease over its 2021 EPS that were of -2,21ย โ‚ฌ.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,01ย โ‚ฌ-9.78%
2022-2,23ย โ‚ฌ0.83%
2021-2,21ย โ‚ฌ-61.3%
2020-5,72ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,99ย โ‚ฌ 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA